Other

Accrued expenditures for intangible assets at September 30,

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2025
Last reportedQ1 2026May 1, 2026
Metric ID: other_intangible_asset_expenditures_incurred_but_not_yet_paid

Historical Data

2 periods
 Q1 '25Q1 '26
Value$0.00$74.00M
Range$0.00 – $74.00M

Frequently Asked Questions

What is Moderna's accrued expenditures for intangible assets at september 30,?
Moderna (MRNA) reported accrued expenditures for intangible assets at september 30, of $74.00M in Q1 2026.